Early research (Phase 1)Looking for participantsNCT06768489
What this trial is testing
JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaImmunoglobulin Light-chain Amyloidosis
Janssen Research & Development, LLC 276